Caption Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-282,500
Closed -$17.7M 1759
2025
Q3
$17.7M Buy
+282,500
New +$15.4M 0.14% 161
2025
Q2
Sell
-82,400
Closed -$3.51M 1631
2025
Q1
$3.51M Buy
+82,400
New +$3.56M 0.03% 503
2024
Q4
Sell
-150,700
Closed -$3.46M 1594
2024
Q3
$3.46M Hold
150,700
0.06% 393
2024
Q2
$4.35M Buy
150,700
+117,400
+353% +$2.73M 0.07% 290
2024
Q1
$687K Buy
+33,300
New +$714K 0.01% 819
2022
Q4
Sell
-504,300
Closed -$27.1M 1420
2022
Q3
$27.1M Buy
504,300
+474,300
+1,581% +$24.4M 0.37% 47
2022
Q2
$1.21M Buy
+30,000
New +$1.49M 0.02% 816
2022
Q1
Sell
-1,300
Closed -$130K 1634
2021
Q4
$130K Buy
+1,300
New +$134K ﹤0.01% 1464
2020
Q1
Sell
-90,000
Closed -$7.03M 933
2019
Q4
$7.03M Buy
+90,000
New +$6.49M 0.24% 107

Other funds holding GH

Caption Management's GH Position: Q1 2026 in Review

Caption Management opened a new position in Guardant Health (GH) in Q1 2026: 115,183 shares worth $10.6M. The stake represents 0.06% of the portfolio and ranks #311 among its holdings. This is a return to the name: Caption Management previously reported a position in GH as recently as Q1 2025.

Caption Management first reported a position in GH in Q4 2019 and has held it in 12 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Caption Management held 115,183 shares of Guardant Health worth $10.6M as of Q1 2026.
  • Guardant Health was a new Caption Management position in Q1 2026.
  • Guardant Health made up 0.06% of Caption Management's portfolio in Q1 2026, its #311 holding.
  • Caption Management first reported a position in Guardant Health in Q4 2019 and has held it in 12 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.